Tamarack Advisers’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-2,500,000
| Closed | -$1.02M | – | 41 |
|
|
2019
Q4 | $1.02M | Sell |
2,500,000
-2,000,000
| -44% | -$815K | 0.23% | 25 |
|
|
2019
Q3 | $9M | Buy |
4,500,000
+1,150,000
| +34% | +$2.3M | 2.35% | 14 |
|
|
2019
Q2 | $7.44M | Buy |
3,350,000
+950,000
| +40% | +$2.11M | 2.26% | 16 |
|
|
2019
Q1 | $7.58M | Buy |
2,400,000
+275,000
| +13% | +$869K | 3.01% | 12 |
|
|
2018
Q4 | $5.29M | Buy |
2,125,000
+65,000
| +3% | +$162K | 2.16% | 15 |
|
|
2018
Q3 | $8.28M | Buy |
2,060,000
+60,000
| +3% | +$241K | 2.36% | 17 |
|
|
2018
Q2 | $7.56M | Buy |
2,000,000
+125,000
| +7% | +$473K | 2.53% | 14 |
|
|
2018
Q1 | $4.35M | Hold |
1,875,000
| – | – | 2.07% | 15 |
|
|
2017
Q4 | $2.91M | Buy |
1,875,000
+125,000
| +7% | +$194K | 1.59% | 21 |
|
|
2017
Q3 | $3.73M | Sell |
1,750,000
-50,000
| -3% | -$107K | 2.28% | 15 |
|
|
2017
Q2 | $8.14M | Sell |
1,800,000
-25,000
| -1% | -$113K | 4.75% | 9 |
|
|
2017
Q1 | $5.49M | Hold |
1,825,000
| – | – | 3.43% | 15 |
|
|
2016
Q4 | $5.04M | Sell |
1,825,000
-375,000
| -17% | -$1.04M | 3.56% | 13 |
|
|
2016
Q3 | $6.94M | Buy |
+2,200,000
| New | +$6.94M | 2.18% | 16 |
|